Literature DB >> 15863833

The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor.

Jose Ruiz1, Diana Kouiavskaia, Molly Migliorini, Susan Robinson, Evgueni L Saenko, Natalia Gorlatova, Donghua Li, Daniel Lawrence, Bradley T Hyman, Karl H Weisgraber, Dudley K Strickland.   

Abstract

Apolipoprotein E (apoE) associates with lipoproteins and mediates their interaction with members of the LDL receptor family. ApoE exists as three common isoforms that have important distinct functional and biological properties. Two apoE isoforms, apoE3 and apoE4, are recognized by the LDL receptor, whereas apoE2 binds poorly to this receptor and is associated with type III hyperlipidemia. In addition, the apoE4 isoform is associated with the common late-onset familial and sporadic forms of Alzheimer's disease. Although the interaction of apoE with the LDL receptor is well characterized, the specificity of other members of this receptor family for apoE is poorly understood. In the current investigation, we have characterized the binding of apoE to the VLDL receptor and the LDL receptor-related protein (LRP). Our results indicate that like the LDL receptor, LRP prefers lipid-bound forms of apoE, but in contrast to the LDL receptor, both LRP and the VLDL receptor recognize all apoE isoforms. Interestingly, the VLDL receptor does not require the association of apoE with lipid for optimal recognition and avidly binds lipid-free apoE. It is likely that this receptor-dependent specificity for various apoE isoforms and for lipid-free versus lipid-bound forms of apoE is physiologically significant and is connected to distinct functions for these receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15863833     DOI: 10.1194/jlr.M500114-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  84 in total

1.  Conformational analysis of apolipoprotein E3/E4 heteromerization.

Authors:  Kai-Han Tu; Devan Abhari; Vasanthy Narayanaswami
Journal:  FEBS J       Date:  2019-03-13       Impact factor: 5.542

2.  Protection of neurons from apoptosis by apolipoprotein E-containing lipoproteins does not require lipoprotein uptake and involves activation of phospholipase Cgamma1 and inhibition of calcineurin.

Authors:  Hideki Hayashi; Robert B Campenot; Dennis E Vance; Jean E Vance
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

Review 3.  Sortilin, a novel APOE receptor implicated in Alzheimer disease.

Authors:  Anne-Sophie Carlo
Journal:  Prion       Date:  2013-10-11       Impact factor: 3.931

4.  Ligand-induced homotypic and heterotypic clustering of apolipoprotein E receptor 2.

Authors:  Shailaja D Divekar; Teal C Burrell; Jennifer E Lee; Edwin J Weeber; G William Rebeck
Journal:  J Biol Chem       Date:  2014-04-22       Impact factor: 5.157

Review 5.  The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  Hong-liang Zhang; Jiang Wu; Jie Zhu
Journal:  J Biomed Biotechnol       Date:  2010-02-16

6.  Fibrin-VLDL Receptor-Dependent Pathway Promotes Leukocyte Transmigration by Inhibiting Src Kinase Fyn and is a Target for Fibrin β15-42 Peptide.

Authors:  Sergiy Yakovlev; Chunzhang Cao; Rebeca Galisteo; Li Zhang; Dudley K Strickland; Leonid Medved
Journal:  Thromb Haemost       Date:  2019-08-29       Impact factor: 5.249

Review 7.  Therapeutic targeting of nuclear receptors, liver X and retinoid X receptors, for Alzheimer's disease.

Authors:  Nicholas F Fitz; Kyong Nyon Nam; Radosveta Koldamova; Iliya Lefterov
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

8.  Interaction of Fibrin with the Very Low Density Lipoprotein Receptor: Further Characterization and Localization of the Fibrin-Binding Site.

Authors:  Sergiy Yakovlev; Leonid Medved
Journal:  Biochemistry       Date:  2015-07-21       Impact factor: 3.162

Review 9.  The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Hong-Liang Zhang; Jiang Wu; Jie Zhu
Journal:  Clin Dev Immunol       Date:  2010-05-31

10.  Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking.

Authors:  Rodrigo A Fuentealba; Qiang Liu; Juan Zhang; Takahisa Kanekiyo; Xiaoyan Hu; Jin-Moo Lee; Mary Jo LaDu; Guojun Bu
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.